ASIX FY2025 SEC EDGAR DEF 14A #68 of 168 in industry

AdvanSix Inc. CEO pay ratio

The CEO earned $5.6M in FY2025 against median worker pay of $110,269 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#68/168

Data updated August 2026

Subscribe to AdvanSix Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
51:1
Moderate (Scale: 0–1000:1)
CEO pay
$5.6M
Median worker
$110,269

Answer first

AdvanSix Inc.'s FY2025 CEO total of $5.6M ranks #875 of 1,423 complete filings; its 51:1 pay ratio ranks #966. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $110,269. Industry placement uses the FY2025 SIC-28 peer cohort (# 68 of 168, 60th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#875
$5.6M of 1,423 FY2025
Ratio rank
#966
51:1 of 1,423
Industry pct
60th
above the industry median pay ratio

How AdvanSix Inc. ranks nationally

AdvanSix Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$5,647,438 39th percentile higher than 39% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

AdvanSix Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($5.6M) against pay ratio (51:1) for AdvanSix Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both4568585.58942721.81331685817690994.322065130.541.5:144.3:147:149.8:152.5:1CEO total payPay ratio (CEO : median worker)AdvanSix Inc., CEO total pay: 5647438 · Pay ratio (CEO : median worker): 51:1AdvanSix Inc.AbCellera Biologics Inc., CEO total pay: 6350188 · Pay ratio (CEO : median worker): 52:1AbCellera Biologics Inc.Viking Therapeutics, Inc., CEO total pay: 21269833 · Pay ratio (CEO : median worker): 49:1Viking Therapeutics, Inc.Lsb Industries, Inc., CEO total pay: 5363883 · Pay ratio (CEO : median worker): 49:1Lsb Industries, Inc.Neurocrine Biosciences Inc, CEO total pay: 13448935 · Pay ratio (CEO : median worker): 49:1Neurocrine Biosciences Inc
AdvanSix Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in AdvanSix Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · AdvanSix Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
51:1
FY2025
vs prior FY
+2:1
from FY2024 49:1
CEO $ YoY
+1%
$5.6M latest
Filings shown
5
FY2021–2025
AdvanSix Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $5.8M - $118,305 49:1 -
2022 $5.3M -7.5% $103,778 51:1 +2:1
2023 $4.7M -11% $98,910 48:1 -3:1
2024 $5.6M +18% $114,213 49:1 +1:1
2025 $5.6M +1% $110,269 51:1 +2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1673985, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
51:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.6M
Companies in Industry
168
vs. Industry Median
Above
#68 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

AdvanSix Inc.: MODEST · MID$ pay ratio

AdvanSix Inc.'s 51:1 ratio ranks #966 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 51× the median employee ($110,269) in FY2025.

Median employee $110,269 (HIGH-MED); MODEST · MID$ stamps put about 51 median-wage years per CEO year.

CEO Total Pay

$5.6M

FY2025 Summary Compensation, below median

Pay Ratio

51:1

Near industry median

AdvanSix Inc. in the lower-ratio third

AdvanSix Inc.'s 51:1 ratio ranks #966 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; AdvanSix Inc.'s $5.6M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #875 and ratio rank #966 split - treat 51:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$5.6M
Median Employee Pay
$110,269
Pay Ratio
51:1
Filing Date
2026-04-29

Company Info

Ticker
ASIX
CIK
1673985
Industry
Chemicals & Pharmaceuticals
SIC Code
2821
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1673985, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. AdvanSix Inc.'s 51:1 ratio ranks #966 of 1,423 FY2025 complete filings (lower third by ratio).

Read with AdvanSix Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · HIGH-MED.

Akebia Therapeutics, Inc. · MID$

ABS(ceo_total_comp) peer at $5.7M (Δ $5K heavier vs AdvanSix Inc.); FLOOR · ELITE-MED vs this page's MODEST · MID$ · HIGH-MED.
Primerica, Inc. · MID$

ABS(ceo_total_comp) peer at $5.6M (Δ $15K lighter vs AdvanSix Inc.); MID · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Unisys Corp · MID$

ABS(ceo_total_comp) peer at $5.6M (Δ $22K lighter vs AdvanSix Inc.); STEEP · LOW-MED vs this page's MODEST · MID$ · HIGH-MED.
Popular, Inc. · MID$

ABS(ceo_total_comp) peer at $5.7M (Δ $32K heavier vs AdvanSix Inc.); MID · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Novavax Inc (SIC 28 pole)

Novavax Inc stamps MODEST · UNFILED nearest in-SIC by ABS(pay_ratio) to AdvanSix Inc.'s MODEST filing.
National dual ranks · #875/#966

AdvanSix Inc.'s FY2025 package sits #875 by CEO dollars and #966 by ratio under MID$ · MODEST.
Ratio primer · MODEST

AdvanSix Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for AdvanSix Inc. (CIK 1673985), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.